The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Incyte; Sandoz; Seagen
Speakers' Bureau - Incyte; Seagen
Response rate to lenalidomide plus rituximab (R2) as independent of number of prior lines of therapy: Interim analysis of initial phase of MAGNIFY phase IIIb study of R2 followed by maintenance in relapsed/refractory indolent NHL.
 
David Andorsky
Consulting or Advisory Role - CTI; Genentech
Research Funding - Bristol-Myers Squibb; Celgene; CTI; Gilead Sciences
 
Morton Coleman
Stock and Other Ownership Interests - Kite, a Gilead company
Consulting or Advisory Role - Bayer; Celgene; Gilead Sciences
Speakers' Bureau - Bayer; Celgene; Gilead Sciences; Pharmacyclics
Research Funding - Bayer; Celgene; Gilead Sciences; Incyte; Merck
 
Abdulraheem Yacoub
No Relationships to Disclose
 
Jason M. Melear
No Relationships to Disclose
 
Heather Dawn Brooks
No Relationships to Disclose
 
Suzanne R. Fanning
Speakers' Bureau - Celgene; Takeda
 
Kathryn S. Kolibaba
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences; Seagen
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Celgene (Inst); Cell Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Frederick Lansigan
Consulting or Advisory Role - Celgene; Spectrum Pharmaceuticals
Research Funding - Spectrum Pharmaceuticals (Inst)
 
Chris Reynolds
No Relationships to Disclose
 
Jiahui Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Dongfang Liu
Employment - Bristol-Myers Squibb (I); Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb (I); Celgene
Patents, Royalties, Other Intellectual Property - Momenta Pharmaceuticals
 
Mary Llorente
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Justin L. Ricker
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jeff Porter Sharman
Leadership - US Oncology
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics; TG Therapeutics
Speakers' Bureau - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences